BFRI — Biofrontera Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Biofrontera, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8.2	24.7	27.8	1.42	5.91
Net Total Accounts Receivable
Net Total Receivables	3.29	12.4	7.41	5.16	5.32
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19.6	46.4	43.1	23.1	20.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.37	0.267	1.58	1.75	0.983
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	24.1	53.2	50.9	27.9	22.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.42	13.8	20.9	18.1	12
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.3	41.9	27	23.1	17.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	5.83	11.3	23.9	4.79	4.43
Total Liabilities & Shareholders' Equity	24.1	53.2	50.9	27.9	22.1
Total Common Shares Outstanding